ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BRM Biorem Inc

3.20
0.04 (1.27%)
27 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biorem Inc TSXV:BRM TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.04 1.27% 3.20 3.16 3.25 3.29 3.12 3.20 38,788 21:00:01

Biorem Reports Record Quarterly Revenues and Earnings, - $14.9 Million of Revenues in the Quarter and Quarterly EPS of $0.14

06/11/2024 1:00pm

PR Newswire (Canada)


Biorem (TSXV:BRM)
Historical Stock Chart


From Oct 2024 to Dec 2024

Click Here for more Biorem Charts.

GUELPH, ON, Nov. 6, 2024 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2024. BIOREM's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

FINANCIAL HIGHLIGHTS:

 in Canadian dollars, '000's except earnings per share



Three-months ended

Nine-months ended


September 30

September 30


2024

2023

2024

2023






Revenue

14,886

5,509

28,104

12,959

Gross profit

5,021

1,544

8,458

2,615

Operating expenses

1,992

806

4,401

2,630

Ebitda*

3,138

787

4,391

170

Net earnings (loss)

2,192

503

2,873

(147)

EPS - basic

0.14

0.03

0.18

(0.01)

EPS - fully diluted

0.12

0.03

0.16

(0.01)

* Earnings before interest, taxes and amortizaton, a non IFRS financial measure

BIOREM reported record quarterly revenues for the third quarter of $14.9 million, an increase of 103% over the previous quarter and 170% higher than the $5.5 million of revenues reported in the same quarter in 2023. Year to date revenues totalled $28.1 million, a 117% increase over the $13 million reported for the first nine months of 2023. The increase in revenues for the first nine months of 2024 compared to the prior year is largely attributable to the increase in order bookings and continuing delivery of projects from the Company's large order backlog.

During the quarter the Company booked $6.6 million in new orders resulting in an order backlog of $48.4 million on September 30, 2024. This compares to an order backlog of $57 million on June 30, 2024 and $54.5 million as of September 30, 2023.

The Company expects order bookings to continue to grow as and delivery of projects from the order backlog continues generating strong revenue and earnings growth over the next 12 months.

"In the third quarter, delays related to industry-wide issues with construction projects eased somewhat, allowing BIOREM to catch up on orders in the Company's backlog," said Derek S. Webb, President and CEO. "Even as project deliveries accelerated, BIOREM's sales funnel, outstanding bids and order backlog remain robust with no signs of softening over the near- to medium-term."

"Population growth and the need for significant increases in housing construction throughout North America is driving demand for municipal and industrial infrastructure projects that require air emission abatement systems. BIOREM's experience and performance in delivering both large and small successful air emission abatement projects makes them uniquely positioned to benefit over the long term from this growth cycle".

Gross profit for the quarter was $5 million or 33.7% of revenue compared to $1.5 million of gross profit representing 28% of revenue recorded during the third quarter of 2023. Total operating expenses (net of other income) for the quarter were $1.9 million against $806,000 in the same period the prior year. The increase in operating expenses in 2024 was primarily due to higher sales and marketing costs and general and administrative expenses. Ebitda for the quarter was $3.1 million compared to $787,000 million of ebitda in the third quarter of 2023.

The Company reported net earnings for the quarter of $2.2 million or $0.14 per share. Year to date the Company reported earnings of $2.9 million compared to a net loss of $147,000 for the first nine months of 2023.

Cash on hand on September 30, 2024 increased to $7.3 million. Earnings from operating activities during the quarter generated $3.1 million of cash and net increases in non-cash working capital items used $125,000 million of cash reserves. Working capital on September 30, 2024 increased to $10.4 million.

About BIOREM Inc.

BIOREM is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 2000 installed systems worldwide, BIOREM offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.

SOURCE Biorem Inc.

Copyright 2024 Canada NewsWire

1 Year Biorem Chart

1 Year Biorem Chart

1 Month Biorem Chart

1 Month Biorem Chart